Toxicity Attributed to Genetic Polymorphisms in Testicular Germ Cell Tumor Survivors

NCT02303015 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 430

Last updated 2023-11-21

No results posted yet for this study

Summary

The purpose of this study is to identify genetic variations in survivors of testicular cancer and connect these variations to differences in risks of late effects.

Conditions

  • Germ Cell Cancer

Sponsors & Collaborators

  • Rigshospitalet, Denmark

    lead OTHER

Principal Investigators

  • Gedske Daugaard, MD DMSc · Rigshospitalet, Denmark

Eligibility

Min Age
15 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2023-03-31
Completion
2023-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02303015 on ClinicalTrials.gov